An early detection, no-contact medical device that monitors a patient’s heart rate, respiration rate and movement has entered beta testing at three hospitals.
Sensiotec‘s Virtual Medical Assistant received 501(k) clearance from the U.S. Food and Drug Administration about a year ago.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The device obtains patient vital signs data via a sensor array that can be positioned in a number of places, such as under a patient’s bed or on the ceiling, for example.
That data can then be sent to over the web to nursing stations, mobile phones and the like to alert caregivers to changes in vital signs.
“We can extend vital signs monitoring of a hospital, long-term care or home care environment to a larger patient population at a fraction of the cost of conventional monitoring,” Sensiotec CEO Robert Arkin said in an interview at the American Telemedicine Association‘s 2012 conference.
The device is in beta testing at three hospitals, including Baptist Health System in Birmingham.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In the video below, Arkin talks about Atlanta-based Sensiotec’s patient monitoring technology.
